Champions Oncology's (CSBR) CEO Ronnie Morris on Q1 FY2022 Results - Earnings Call Transcript

Sep. 14, 2021 12:51 PM ETChampions Oncology, Inc. (CSBR)
SA Transcripts profile picture
SA Transcripts

Champions Oncology Inc. (NASDAQ:CSBR) Q1 FY2022 Earnings Conference Call September 13, 2021 4:30 PM ET

Company Participants

Ronnie Morris – President and Chief Executive Officer

David Miller – Chief Financial Officer

Conference Call Participants

Matt Hewitt – Craig-Hallum Capital


Good day, ladies and gentlemen, and welcome to the Champions Oncology’s First Quarter Fiscal Year 2022 Earnings Call. [Operator Instructions]

At this time, it is my pleasure to turn the floor over to your host Ronnie Morris, CEO of Champions Oncology. Sir, the floor is yours.

Ronnie Morris

Good afternoon. I am Ronnie Morris, CEO of Champions Oncology. Joining me today is David Miller, CFO. Thank you for joining us for our quarterly earnings call.

Before I begin, I will remind you that we will be making forward-looking statements during today's call and that actual results could differ materially from what is described in those statements. Additional information on factors that could cause results to differ is available in our Forms 10-Q and Form 10-K. A reconciliation of the non-GAAP financial measures that may be discussed during the call to GAAP financial measures is available in the earnings release.

I will start by pointing out that our prepared comments for today will be relatively brief, as we just recently provided our fiscal year end results and company update six weeks ago.

On that call, I outlined our transformative strategic vision for the next few years. While we continue to progress on this execution during the first quarter, the fundamental message and status remain unchanged. Our oncology research services business, which includes in vivo and ex vivo studies, along with an extensive array of biomarker assays, continues to grow and deliver successful results, supporting our investment in other opportunities that will accelerate our long-term revenue growth.

Our differentiating factor continues to

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.